[Fondaparinux and anesthesia].
Llau
J V
JV
De Andrés
J
J
Gomar
C
C
Gómez
A
A
Hidalgo
F
F
Torres
L M
LM
D000765:Anesthesia, Conduction; D000075202:Contraindications; D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D000077425:Fondaparinux; D006406:Hematoma / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans; D011134:Polysaccharides / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics; D011183:Postoperative Complications / Q000517:prevention & control; D019106:Postoperative Hemorrhage / Q000139:chemically induced / Q000517:prevention & control*; D011677:Punctures / Q000009:adverse effects*; D012306:Risk; D013923:Thromboembolism / Q000517:prevention & control; D013997:Time Factors
D065427:Factor Xa Inhibitors; D005343:Fibrinolytic Agents; D011134:Polysaccharides; D000077425:Fondaparinux